Canada markets closed

Khiron Life Sciences Corp. (KHRN.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
0.4700-0.0050 (-1.05%)
At close: 3:56PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2020-12-31
2019-12-31
2018-12-31
2017-12-31
2017-05-31
Total Revenue
8,017
8,017
9,582
891.677
-
0
Cost of Revenue
1,009
1,009
7,147
594.313
-
-
Gross Profit
7,008
7,008
2,436
297.364
-
-
Operating Expenses
Research Development
1,526
1,526
3,733
-
-
-
Selling General and Administrative
28,410
28,410
35,913
20,194
-
44.683
Total Operating Expenses
30,613
30,613
40,016
20,194
-
44.683
Operating Income or Loss
-23,605
-23,605
-37,580
-19,896
-
-44.683
Total Other Income/Expenses Net
-344.916
-344.916
1,225
168.376
-
-
Income Before Tax
-23,950
-23,950
-36,355
-19,728
-
-44.683
Income Tax Expense
88.983
88.983
22.746
78.58
-
-
Income from Continuing Operations
-24,039
-24,039
-36,378
-19,807
-
-44.683
Net Income
-24,039
-24,039
-36,378
-19,807
-
-44.683
Net Income available to common shareholders
-24,039
-24,039
-36,378
-19,528
-
-44.683
Basic EPS
-
-0.20
-0.36
-0.42
-0.14
-0.24
Diluted EPS
-
-0.20
-0.36
-0.42
-0.14
-0.24
Basic Average Shares
-
120,294
101,966
48,519
27,757
189.583
Diluted Average Shares
-
120,294
101,966
48,519
27,757
189.583
EBITDA
-
-22,438
-36,641
-19,558
-
-44.683